Details of the Drug
General Information of Drug (ID: DM4TFN6)
Drug Name |
1-aminobutylphosphonic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
(1-aminobutyl)phosphonic acid; 1-aminobutylphosphonic acid; 13138-36-8; Phosphonic acid, (1-aminobutyl)-; NSC-117799; CHEMBL1089898; Phosphonic acid,P-(1-aminobutyl)-; alpha-Aminobutanephosphonic acid; DL-(1-Aminobutyl)phosphonic acid; Phosphonic acid, P-(1-aminobutyl)-; NSC117799; (+/-)-(1-Aminobutyl)phosphonic acid; J441.089K; AC1Q6RLK; AC1L6SK2; SCHEMBL745916; alpha-aminobutylphosphonic acid; CTK4B7247; BDBM50316029; AKOS015854597; FCH1112358; TRA0100955; KB-00224; TR-032039; DB-042023; FT-0636808; C-51169
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 153.12 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -3.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||